Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Radiation-related lymphopenia is associated with spleen irradiation dose during radiotherapy in patients with hepatocellular carcinoma
Jing Liu, Qianqian Zhao, Weiye Deng, et al.
Radiation Oncology (2017) Vol. 12, Iss. 1
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

A review of proton therapy – Current status and future directions
Radhe Mohan
Precision Radiation Oncology (2022) Vol. 6, Iss. 2, pp. 164-176
Open Access | Times Cited: 116
A review on lymphocyte radiosensitivity and its impact on radiotherapy
Harald Paganetti
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 43
Field size effects on the risk and severity of treatment-induced lymphopenia in patients undergoing radiation therapy for solid tumors
Susannah G. Ellsworth
Advances in Radiation Oncology (2018) Vol. 3, Iss. 4, pp. 512-519
Open Access | Times Cited: 148
Radiotherapy-Related Lymphopenia Affects Overall Survival in Patients With Lung Cancer
A. Abravan, C. Faivre‐Finn, Jason Kennedy, et al.
Journal of Thoracic Oncology (2020) Vol. 15, Iss. 10, pp. 1624-1635
Open Access | Times Cited: 133
Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons
Radhe Mohan, Amy Liu, Paul D. Brown, et al.
Neuro-Oncology (2020) Vol. 23, Iss. 2, pp. 284-294
Open Access | Times Cited: 112
Ultra high dose rate (35 Gy/sec) radiation does not spare the normal tissue in cardiac and splenic models of lymphopenia and gastrointestinal syndrome
Bhanu Prasad Venkatesulu, Amrish Sharma, Julianne Pollard‐Larkin, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 107
Considerations for designing preclinical cancer immune nanomedicine studies
Wen Jiang, Yifan Wang, Jennifer A. Wargo, et al.
Nature Nanotechnology (2020) Vol. 16, Iss. 1, pp. 6-15
Open Access | Times Cited: 100
The Influence of Severe Radiation-Induced Lymphopenia on Overall Survival in Solid Tumors: A Systematic Review and Meta-Analysis
P. Damen, Tiuri E. Kroese, Richard van Hillegersberg, et al.
International Journal of Radiation Oncology*Biology*Physics (2021) Vol. 111, Iss. 4, pp. 936-948
Closed Access | Times Cited: 94
Lymphocyte-Sparing Radiotherapy: The Rationale for Protecting Lymphocyte-rich Organs When Combining Radiotherapy With Immunotherapy
Philippe Lambin, R. Lieverse, Franziska Eckert, et al.
Seminars in Radiation Oncology (2020) Vol. 30, Iss. 2, pp. 187-193
Open Access | Times Cited: 85
Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma
Changhoon Choi, Gyu Sang Yoo, Won Kyung Cho, et al.
World Journal of Gastroenterology (2019) Vol. 25, Iss. 20, pp. 2416-2429
Open Access | Times Cited: 80
Lymphocyte dynamics during and after chemo-radiation correlate to dose and outcome in stage III NSCLC patients undergoing maintenance immunotherapy
Yeona Cho, Yejin Kim, Ibrahim Chamseddine, et al.
Radiotherapy and Oncology (2022) Vol. 168, pp. 1-7
Open Access | Times Cited: 42
Lymphocyte-Sparing Effect of Proton Therapy in Patients with Esophageal Cancer Treated with Definitive Chemoradiation
Penny Fang, Yutaka Shiraishi, Vivek Verma, et al.
International Journal of Particle Therapy (2017) Vol. 4, Iss. 3, pp. 23-32
Open Access | Times Cited: 83
The relationship of lymphocyte recovery and prognosis of esophageal cancer patients with severe radiation-induced lymphopenia after chemoradiation therapy
Wei Deng, Xu Cai, Amy Liu, et al.
Radiotherapy and Oncology (2019) Vol. 133, pp. 9-15
Closed Access | Times Cited: 63
Dose–Volume Constraints fOr oRganS At risk In Radiotherapy (CORSAIR): An “All-in-One” Multicenter–Multidisciplinary Practical Summary
S. Bisello, Savino Cilla, Anna Benini, et al.
Current Oncology (2022) Vol. 29, Iss. 10, pp. 7021-7050
Open Access | Times Cited: 35
Lymphocyte sparing normal tissue effects in the clinic (LymphoTEC): A systematic review of dose constraint considerations to mitigate radiation-related lymphopenia in the era of immunotherapy
BhanuPrasad Venkatesulu, Prashanth Giridhar, Lincoln Pujari, et al.
Radiotherapy and Oncology (2022) Vol. 177, pp. 81-94
Closed Access | Times Cited: 33
Immunological effects of radiopharmaceutical therapy
Amanda G. Shea, Malick Bio Idrissou, Ana Isabel Torres, et al.
Frontiers in Nuclear Medicine (2024) Vol. 4
Open Access | Times Cited: 6
Prediction of Severe Lymphopenia During Chemoradiation Therapy for Esophageal Cancer: Development and Validation of a Pretreatment Nomogram
Peter S.N. van Rossum, Wei Deng, David M. Routman, et al.
Practical Radiation Oncology (2019) Vol. 10, Iss. 1, pp. e16-e26
Open Access | Times Cited: 53
Acute severe lymphopenia by radiotherapy is associated with reduced overall survival in hepatocellular carcinoma
Hwa Kyung Byun, Nalee Kim, Sang Joon Park, et al.
Strahlentherapie und Onkologie (2019) Vol. 195, Iss. 11, pp. 1007-1017
Closed Access | Times Cited: 36
Splenic Hematopoietic and Stromal Cells in Cancer Progression
Jonas Steenbrugge, Emiel A. De Jaeghere, Evelyne Meyer, et al.
Cancer Research (2020) Vol. 81, Iss. 1, pp. 27-34
Open Access | Times Cited: 35
Proton and photon radiotherapy in stage III NSCLC: Effects on hematological toxicity and adjuvant immune therapy
Francesco Cortiula, Lizza E.L. Hendriks, Robin Wijsman, et al.
Radiotherapy and Oncology (2023) Vol. 190, pp. 110019-110019
Open Access | Times Cited: 11
Patient‐specific modeling of radiation‐induced lymphopenia for head and neck cancer
Jiaxin Li, Rahul D. Mali, Gregory N. Gan, et al.
Medical Physics (2025)
Closed Access
Spleen Dose–Volume Parameters as a Predictor of Treatment-related Lymphopenia During Definitive Chemoradiotherapy for Esophageal Cancer
Tetsuo Saito, Ryo Toya, Naoya Yoshida, et al.
In Vivo (2018) Vol. 32, Iss. 6, pp. 1519-1525
Open Access | Times Cited: 35
Lymphopenia in Esophageal Squamous Cell Carcinoma: Relationship to Malnutrition, Various Disease Parameters, and Response to Concurrent Chemoradiotherapy
Xilei Zhou, Weiguo Zhu, Zhijian Zhu, et al.
The Oncologist (2019) Vol. 24, Iss. 8, pp. e677-e686
Open Access | Times Cited: 30
Lymphopenia During Definitive Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Association with Dosimetric Parameters and Patient Outcomes
Hui Xu, Maosheng Lin, Yingying Hu, et al.
The Oncologist (2020) Vol. 26, Iss. 3, pp. e425-e434
Open Access | Times Cited: 28
Lymphopenia and intratumoral lymphocytic balance in the era of cancer immuno-radiotherapy
Michael I. Koukourakis, Alexandra Giatromanolaki
Critical Reviews in Oncology/Hematology (2021) Vol. 159, pp. 103226-103226
Closed Access | Times Cited: 26
Page 1 - Next Page

Scroll to top